| |
| |
|
| Insider
Information: |
Van Naarden Jacob |
| Relationship: |
EVP & Pres., Loxo@Lilly |
| City: |
Stamford |
| State: |
CT |
| |
|
| Insider
Summary: |
|
|
|
|
Companies Owned : |
2 |
|
| Direct
Shares |
16,147 |
|
|
Indirect Shares
|
4,342 |
|
|
| Direct
Value |
$13,037,572 |
|
|
|
Indirect Value
|
$3,505,861 |
|
|
| Total
Shares |
20,489 |
|
|
| Total
Value |
$16,543,433 |
|
|
|
|
|
|
|
|
Historical
Performance :
Based on 6 Month Return Percentages |
Buys
|
Sells
|
|
Total
Filings :
|
0
|
0
|
|
Stock
price went up :
|
0
|
0
|
| Stock
price went down : |
0
|
0
|
| |
|
|
|
Gain/Loss Ratio : |
0.0
|
0.0
|
| Percentage
Gain/Loss : |
0.0%
|
0.0%
|
| |
|
|
|
|
|
Holdings
:
| Menu |
Company Name |
Ticker |
Relation |
Direct Date |
Direct Shares |
Indirect Date |
Indirect Shares |
Total Value Sold  |
 |
Loxo Oncology, Inc. |
LOXO |
Chief Operating Officer |
2019-02-15 |
0 |
2017-08-14 |
0 |
Premium* |
|
|
Eli Lilly & Co |
LLY |
EVP & Pres., Loxo@Lilly |
2024-02-12 |
16,147 |
2024-02-12 |
4,342 |
Premium* |
|
|
|
|
|
|
|
|
|
|
|
Records found :
80 |
Free Registration Required For Full Results. Limit: 25
|
 |
Download |
Page 3 of 4
|
| Ticker |
Company Name |
Relation |
Off-Dir-10% |
Trans. Date |
Form |
Action |
Price |
Mkt Value |
D/I |
Shares |
Holdings |
Rank
|
|
|
| 3m +/- |
|
|
Form |
| LOXO |
Loxo Oncology, Inc. |
Chief Business Officer |
• – – |
2017-09-19 |
4 |
AS |
$87.86 |
$136,827 |
D/D |
(1,541) |
0 |
0 |
- |
|
| LOXO |
Loxo Oncology, Inc. |
Chief Business Officer |
• – – |
2017-09-18 |
4 |
AS |
$88.14 |
$137,462 |
D/D |
(1,541) |
0 |
0 |
- |
|
| LOXO |
Loxo Oncology, Inc. |
Chief Business Officer |
• – – |
2018-02-12 |
4 |
AS |
$92.21 |
$143,978 |
D/D |
(1,541) |
0 |
0 |
- |
|
| LOXO |
Loxo Oncology, Inc. |
Chief Business Officer |
• – – |
2018-02-13 |
4 |
AS |
$94.33 |
$152,934 |
D/D |
(1,541) |
0 |
0 |
- |
|
| LOXO |
Loxo Oncology, Inc. |
Chief Business Officer |
• – – |
2018-04-25 |
4 |
AS |
$128.72 |
$201,563 |
D/D |
(1,541) |
0 |
0 |
- |
|
| LOXO |
Loxo Oncology, Inc. |
Chief Business Officer |
• – – |
2018-03-13 |
4 |
AS |
$128.85 |
$202,415 |
D/D |
(1,541) |
0 |
0 |
- |
|
| LOXO |
Loxo Oncology, Inc. |
Chief Business Officer |
• – – |
2018-03-14 |
4 |
AS |
$131.05 |
$202,580 |
D/D |
(1,541) |
0 |
0 |
- |
|
| LOXO |
Loxo Oncology, Inc. |
Chief Business Officer |
• – – |
2018-04-24 |
4 |
AS |
$129.58 |
$202,898 |
D/D |
(1,541) |
0 |
0 |
- |
|
| LOXO |
Loxo Oncology, Inc. |
Chief Business Officer |
• – – |
2018-05-15 |
4 |
AS |
$133.35 |
$211,566 |
D/D |
(1,541) |
0 |
0 |
- |
|
| LOXO |
Loxo Oncology, Inc. |
Chief Business Officer |
• – – |
2018-05-14 |
4 |
AS |
$134.25 |
$211,949 |
D/D |
(1,541) |
0 |
0 |
- |
|
| LOXO |
Loxo Oncology, Inc. |
Chief Business Officer |
• – – |
2018-06-19 |
4 |
AS |
$176.44 |
$272,666 |
D/D |
(1,541) |
0 |
0 |
- |
|
| LOXO |
Loxo Oncology, Inc. |
Chief Business Officer |
• – – |
2018-06-20 |
4 |
AS |
$179.00 |
$276,370 |
D/D |
(1,541) |
12,000 |
0 |
- |
|
| LOXO |
Loxo Oncology, Inc. |
Chief Business Officer |
• – – |
2018-07-10 |
4 |
AS |
$178.39 |
$276,907 |
D/D |
(1,541) |
13,700 |
0 |
- |
|
| LOXO |
Loxo Oncology, Inc. |
Chief Business Officer |
• – – |
2018-07-09 |
4 |
AS |
$185.34 |
$288,631 |
D/D |
(1,541) |
13,700 |
0 |
- |
|
| LLY |
Eli Lilly & Co |
EVP and CEO Loxo@Lilly |
• – – |
2023-02-16 |
4 |
D |
$335.01 |
$440,203 |
D/D |
(1,314) |
11,845 |
0 |
- |
|
| LLY |
Eli Lilly & Co |
SVP, CEO LoxoONC, Pres LlyONC |
• – – |
2022-02-16 |
4 |
D |
$243.84 |
$533,034 |
D/D |
(2,186) |
7,967 |
0 |
- |
|
| LOXO |
Loxo Oncology, Inc. |
Chief Business Officer |
• – – |
2018-12-10 |
4 |
AS |
$130.59 |
$601,434 |
D/D |
(4,500) |
13,700 |
0 |
- |
|
| LOXO |
Loxo Oncology, Inc. |
Chief Business Officer |
• – – |
2018-12-11 |
4 |
AS |
$134.74 |
$618,080 |
D/D |
(4,500) |
13,700 |
0 |
- |
|
| LOXO |
Loxo Oncology, Inc. |
Chief Business Officer |
• – – |
2018-11-27 |
4 |
AS |
$138.08 |
$637,481 |
D/D |
(4,500) |
13,700 |
0 |
- |
|
| LOXO |
Loxo Oncology, Inc. |
Chief Business Officer |
• – – |
2018-08-14 |
4 |
AS |
$159.08 |
$719,642 |
D/D |
(4,500) |
13,700 |
0 |
- |
|
| LOXO |
Loxo Oncology, Inc. |
Chief Business Officer |
• – – |
2018-10-04 |
4 |
AS |
$160.62 |
$731,884 |
D/D |
(4,500) |
13,700 |
0 |
- |
|
| LOXO |
Loxo Oncology, Inc. |
Chief Business Officer |
• – – |
2018-09-13 |
4 |
AS |
$165.45 |
$746,903 |
D/D |
(4,500) |
13,700 |
0 |
- |
|
| LLY |
Eli Lilly & Co |
EVP and CEO Loxo@Lilly |
• – – |
2023-02-10 |
4 |
A |
$345.12 |
$830,704 |
D/D |
2,407 |
10,374 |
0 |
- |
|
| LOXO |
Loxo Oncology, Inc. |
Chief Business Officer |
• – – |
2018-11-26 |
4 |
AS |
$151.71 |
$842,224 |
D/D |
(5,500) |
13,700 |
0 |
- |
|
| LOXO |
Loxo Oncology, Inc. |
Chief Business Officer |
• – – |
2018-08-13 |
4 |
AS |
$157.62 |
$873,804 |
D/D |
(5,500) |
13,700 |
0 |
- |
|
80 Records found
|
|
Page 3 of 4 |
| |
Free Registration Required For Full Results. Limit: 25
|
|
| |
Transaction Code Key: |
Ownership Code Key |
| |
B |
- Buy |
AB |
- Automatic Buy |
D |
- Direct Ownership |
| |
S |
- Sell |
AS |
- Automatic Sell |
I |
- Indirect Ownership |
|
OE |
- Options Exercised |
A |
- Aquired |
| |
IO |
- Initital Ownership |
D |
- Disposed |
| |
|
|
|
|
|
